Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.
Home 2022
Archives
Tuberculosis drug regimens and their efficacies
Andrew Nunn, Professor of Epidemiology in the Medical Research Council Clinical Trials Unit at UCL, analyses different tuberculosis drug development regimens.
Treating multi-drug resistant tuberculosis
Andrew Nunn, Professor of Epidemiology, Medical Research Council Clinical Trials Unit at UCL, describes the first phase 3 trial of a shortened treatment for MDR-TB.
